Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

CUSIP: 03836J201

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
9,144,889
Total 13F shares
881,553
Share change
+33,316
Total reported value
$2,776,892
Price per share
$3.15
Number of holders
17
Value change
+$105,033
Number of buys
9
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 03836J201?
CUSIP 03836J201 identifies APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q2 2023

As of 30 Jun 2023, Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 881,553 shares. The largest 10 holders included AIGH Capital Management LLC, Sio Capital Management, LLC, Walleye Capital LLC, Worth Venture Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Inc., Tower Research Capital LLC (TRC), and GROUP ONE TRADING, L.P.. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.